XETR
CHG
Market cap259mUSD
Sep 25, Last price
13.70EUR
Name
MEDIQON Group AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating across the DACH region, MEDIQON Group AG and its subsidiaries specialize in delivering a diverse portfolio of software solutions. Their offerings encompass general management platforms, specialized practice management tools for veterinarians, modular systems tailored for sheet metal processing businesses, and applications supporting building-related services. Furthermore, MEDIQON develops software for construction process management, comprehensive enterprise resource planning (ERP) systems covering core functions like sales, procurement, inventory, customer relationship management, and financial accounting, alongside bespoke ERP solutions for mid-sized enterprises. A notable product is Atlantis, their school administration software. Beyond its digital services, the group diversifies its operations by running a language school, managing the import and distribution of cable protection products, and providing expert services in the design, consultation, and installation of refrigeration, air conditioning, and air purification systems. Established in 1998 as medical Columbus AG, the company, now known as MEDIQON Group AG, is headquartered in Königstein, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||